OpenRFPCloses Dec 7, 2026, 12:00 PM CT

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Defense Health Agency (dha) — DEFENSE HEALTH AGENCYSan Antonio, Texas#HT9402-27-Q-9101

The UF BPA will cover prices for Military Treatment Facilities (MTFs) and TRICARE Mail Order Pharmacy (TMOP), while the UF ADP will cover refunds for pharmaceuticals dispensed by TRICARE retail network pharmacies. The P&T Committee will review drug classes for formulary placement based on clinical and cost-effectiveness. A pre-quotation teleconference is scheduled for November 17, 2026.

On PublicBidSearch: the original bid posting, 6 bid documents and the agency contact (name and email) for this bid.

Open Original Bid Source Pro

Contact

Agency contact for this bidName and email — included with ProPro

Overview

Due
Dec 7, 2026, 12:00 PM CT
Time stated in bid documents
Dec 7, 2026, 12:00 PM Central Time
Submission
email
Documents analyzed
6
Required submission items
21 items · full checklist with Pro

Scope of work

  • Solicits quotes for pharmaceutical agents for placement on the DoW Uniform Formulary (UF).
  • Awards may include Uniform Formulary Blanket Purchase Agreements (UF BPA) and Uniform Formulary Additional Discount Program Agreements (UF ADP).
  • P&T Committee will review Ophthalmic - Dry Eye and Testosterone Replacement Therapy - Orals drug classes in February 2027.

Steps to Bid

  1. 1

    Download Utilization Dataset and National Drug Code (NDC) Price List from the website listed in 2.3.2.

  2. 2

    Complete applicable pages and price appendices for quote(s) submitted.

    For ADP quotes: Appendix 3, pp 19-25, UF ADP Appendix. For BPA quotes: Appendix 2, pp 11-18, UF BPA Appendix. For all quotes: Appendix 1, p10 Manufacturer Quote Submission Checklist.

  3. 3

    Send original signed quote(s) and NDC Price List to RFQ Point of Contact (POC) listed in 2.3.

What you'll need

Submission

Email

NAICS

325412

How to submit

Send all submissions electronically to RFQ POC listed in part 2.3.

Pursuit snapshot

Pro
  • Go / no-go verdict on every requirement
  • 10 watch-outs that disqualify bidders
  • The 21-item required-submittals checklist
Unlock with Pro — $20/mo

Cancel anytime · no card to browse

Project details

The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS), which includes the purchase of pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. This process is described in the attached RFQ. The following Drug Classes/subclasses will be reviewed in the February 2027 P&T Committee meeting: Ophthalmic - Dry Eye (Cequa, Eysuvis, Miebo, Tryptyr, Tyrvaya, Verkazia, Vevye, Xiidra) and Testosterone Replacement Therapy - Orals (Jatenzo, Kyzatrex, Tlando). The RFQ, including UF BPA and UF ADP appendices, are attached. Instructions, deadlines, and points of contact are in RFQ HT9402-27-Q-9101.

Key dates

Bids due
Dec 7, 2026, 12:00 PM CT

Documents

  • RFQ_HT9402-27-Q-9101.pdf26 pages
  • PL_-_Ophthalmic_-_Dry_Eye.xlsx
  • PL_-_Testosterone_Replacement_Therapy_-_Orals.xlsx
  • FAR_52-225-6-Certificate.pdf1 pages
  • Feb_2027_PandT_Meeting_Reporting.xlsx
  • NDC_Price_List_FAQ_Class_Review.pdf2 pages

See all documents · Download with Pro

More from this agency

Similar open bids

Closing this week nearby